Address And Details

Guggenheim Investments, P.O. Box 758567 , Topeka, KS 66675
Fund Manager Michael Byrum
Manager Tenure 17 Years 6 Months

Strategy And Objective

The S&P MidCap 400 ® Pure Value Fund (the Fund ) seeks to provide investment results that match, before fees and expenses, the performance of a benchmark for mid-cap value securities on a daily basis. The Fund s current benchmark is the S&P MidCap 400 Pure Value Index (the underlying index ). The Fund employs as its investment strategy a program of investing in the common stock of companies that are generally within the capitalization range of the underlying index and derivative instruments, which primarily consist of equity index swaps, futures contracts, and options on securities,futures contracts, and stock indices. While the Fund may write (sell) and purchase swaps, it expects primarily to purchase swaps. Equity index swaps and futures and options contracts enable the Fund to pursue its investment objective without investing directly in the securities included in the underlying index or in the same proportion that those securities are represented in the underlying index. Certain of the Fund s derivatives investments may be traded in the over-the-counter ( OTC ) market. Under normal circumstances, the Fund will invest at least 80% of its net assets,plus any borrowings for investment purposes, in securities of companies in the underlying index and derivatives and other instruments whose performance is expected to correspond to that of the underlying index.

Net Asset Value

as of 5:30 PM ET 09/16/2021

Performance

  • 1 Week
  • +0.06%
  • 1 Month
  • -1.99%
  • 3 Months
  • -1.01%
  • 1 Yr Return
  • +58.30%
  • 5 Yr Return
  • +60.85%

Equity Sector Breakdown

Finance 35.40%
RetailTrade 15.69%
Technology 13.10%
IndustrialCyclical 9.07%
NonDurables 6.46%
ConsumerDurables 4.95%
Services 3.70%
Energy 3.22%
Utilities 2.11%
Health 1.01%

Asset Allocation

Asset Type % Of Allocation
Stocks 99.41%
Cash 0.00%
Bonds 0.00%
Preferred 0.00%
Convertible 0.00%
Other 0.00%
ForeignStocks 0.00%
ForeignBonds 0.00%
ForeignHedged 0.00%
Total Net Assets 73.15 M

Risk Measures

Criteria 3 Years 5 Years 10 Years
Alpha -14.34 -12.61 -9.44
Beta 1.68 1.62 1.47
R Squared 0.82 0.77 0.75
Std Deviation 34.36 27.72 22.78
Sharpe Ratio 0.42 0.52 n/a

Purchase Information

as of 5:38 PM ET 09/15/2021
Minimum Initial $2500
Minimum Additional $0
Minimum Initial IRA $1000

Performance

Timeframe Average Annual Current Performance Monthly As Of 08/31/2021 Average Annual Current Performance Quarterly As Of 06/30/2021 Avg Annual Current Performance Monthly As Of 08/31/2021 Avg Annual Current Performance Quarterly As Of 06/30/2021
1 Year
  • +64.30%
  • +80.48%
+64.30% +80.48%
3 Year
  • +9.02%
  • +9.21%
+9.02% +9.21%
10 Year
  • +11.43%
  • +9.64%
+11.43% +9.64%
Life Of Fund
  • +7.54%
  • +7.45%
+7.54% +7.45%

Top 10 Holdings

Symbol Company Name % Of Assets
HFC HOLLYFRONTIER CORP 2.23%
TDS TELEPHONE & DATA SYSTEMS I 2.22%
NAVI NAVIENT CORPORATION 2.14%
AVT AVNET INC 2.11%
CMC COMMERCIAL METALS CO 2.05%
KSS KOHLS CORP 1.85%
INT WORLD FUEL SERVICES CORP 1.79%
AN AUTONATION INC 1.79%
GHC GRAHAM HOLDINGS COMPANY 1.79%
SNX SYNNEX CORP 1.76%

Recent Articles from TheStreet

Hong Kong Stocks Slump On Tech Sector Worries As US Official Signals Flaws In China Trade Deal

Intraday Reversals Signal Struggles for Market

But James "Rev Shark" Deporre says the trading action is both normal, and appropriate for September, and he's been adding some names to his portfolio.

stocks market index sh

Cramer's Mad Money Recap: FedEx, Costco, Nike

Jim Cramer says this is a rough season for stock, and investors need to take defensive action.

anxiety grocery mask sh

Jensen: Economy Has a Bearish Outlook

Real Money's Bret Jensen says a slower-than-expected pandemic recovery is a warning for the stock market.

Pfizer vaccine Lead

FDA Panel Recommends Covid Booster Shots for 65, Older and Those at High Risk

Food and Drug Administration's advisory panel on Friday voted to recommend Covid-19 booster shots of the Pfizer vaccine for a limited section of the population.

Ford Lead

Stock Market Today With Jim Cramer: How to Trade Ford

Jim Cramer discusses Ford and the impact of the impending tax policy changes on the stock market.

Jim Cramer: Stay Long Thermo Fisher, Sell FEI

Thermo Fisher Climbs on Strong 2022 Guidance

Thermo Fisher expects revenue to increase 12% year over year next year to $40.3 billion.